{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:23:52Z","timestamp":1774437832035,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.transci.2024.103878","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T13:34:26Z","timestamp":1706448866000},"page":"103878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics of unexpected antibodies in patients with blood disorders: Evidence in Vietnam"],"prefix":"10.1016","volume":"63","author":[{"given":"Vu Duc","family":"Binh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang","family":"Thi Thanh Nga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Ha","family":"Thanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Hoang","family":"Thanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Phu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Quang","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transci.2024.103878_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-157-1-201206190-00429","article-title":"Red blood cell transfusion: a clinical practice guideline from the AABB*","volume":"157","author":"Carson","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.transci.2024.103878_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4097\/kjae.2013.64.1.65","article-title":"A detection of unexpected blood antibody at the time of transfusion was needed, during the operation -a case report","volume":"64","author":"Kim","year":"2013","journal-title":"Korean J Anesthesiol"},{"issue":"3","key":"10.1016\/j.transci.2024.103878_bib3","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201808879","article-title":"Dissecting human antibody responses: useful, basic and surprising findings","volume":"10","author":"Lanzavecchia","year":"2018","journal-title":"EMBO Mol Med"},{"issue":"2","key":"10.1016\/j.transci.2024.103878_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/trf.12176","article-title":"The HI-STAR study: resource utilization and costs associated with serologic testing for antibody-positive patients at four United States medical centers","volume":"54","author":"Mazonson","year":"2014","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.transci.2024.103878_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/trf.13430","article-title":"Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review","volume":"56","author":"Chen","year":"2016","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2024.103878_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17945\/kjbt.2019.30.1.23","article-title":"Prevalence of unexpected antibodies in pregnant Korean Women and neonatal outcomes","volume":"30","author":"Yang","year":"2019","journal-title":"KJBT"},{"issue":"8","key":"10.1016\/j.transci.2024.103878_bib7","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1016\/j.sjbs.2021.04.083","article-title":"The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: a cross-sectional study","volume":"28","author":"Waggiallah","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.transci.2024.103878_bib8","doi-asserted-by":"crossref","DOI":"10.4038\/cmj.v66i2.9472","article-title":"Estimation of prevalence of red cell alloantibodies in patients with Beta Thalassaemia Major in Sri Lanka","author":"Senavirathna","year":"2021","journal-title":"Ceylon Med J"},{"key":"10.1016\/j.transci.2024.103878_bib9","doi-asserted-by":"crossref","DOI":"10.18535\/jmscr\/v7i2.61","article-title":"Prevalence of \u201cunexpected antibodies\u201d in patients requiring blood transfusion at National Referral Hospital, Thimphu from 2015 to 2017: Retrospective study","volume":"7","author":"Yangdon","year":"2019","journal-title":"J Med Sci Clin Res"},{"key":"10.1016\/j.transci.2024.103878_bib10","first-page":"186","article-title":"The rate of irregular red blood cell antibodies and prevalence factors of haematological patients getting blood transfusions in Can Tho hematology blood transfusion hospital in 2020-2021 (Vietnamese)","volume":"40","author":"Minh","year":"2021","journal-title":"Can Tho J Med Pharm"},{"key":"10.1016\/j.transci.2024.103878_bib11","series-title":"Red Blood Cell Alloimmunization after Blood Transfusion","author":"Schonewille","year":"2008"},{"key":"10.1016\/j.transci.2024.103878_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/trf.14508","article-title":"Risks of red blood cell alloimmunization in transfusion-dependent \u03b2-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review","volume":"58","author":"AZ","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103878_bib13","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1016\/j.sjbs.2021.04.083","article-title":"The prevalence of unexpected antibodies in Saudi\u2019s plasma prior blood transfusion and their association with clinical conditions: a cross-sectional study","volume":"28","author":"Waggiallah","year":"2021","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"10.1016\/j.transci.2024.103878_bib14","first-page":"861","article-title":"Analysis of patients' irregular antibody screening and identification results before blood transfusion","volume":"23","author":"Li","year":"2015","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.transci.2024.103878_bib15","first-page":"50","article-title":"Red cell alloimmunization in patients with thalassemia","volume":"58","author":"Spanos","year":"1990","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.transci.2024.103878_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/ijmr.IJMR_940_17","article-title":"Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion","volume":"149","author":"Jariwala","year":"2019","journal-title":"Indian J Med Res"},{"issue":"10","key":"10.1016\/j.transci.2024.103878_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1309\/LMBF1AT2HEVYUS7D","article-title":"Antibody screening in patients with thalassemia major","volume":"42","author":"Obeidi MSc","year":"2011","journal-title":"Lab Med"},{"key":"10.1016\/j.transci.2024.103878_bib18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1537-2995.2002.00126.x","article-title":"Predicting the effect of transfusing only phenotype matched RBCs to patients with sickle cell disease: Theoretical and practical implications","volume":"42","author":"Castro","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103878_bib19","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1182\/blood.V97.12.3999","article-title":"Alloimmunization in Hong Kong southern Chinese transfusion dependent thalassemia patients","volume":"97","author":"Ho","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2024.103878_bib20","first-page":"71","article-title":"Red blood cell alloimmunisation among Chinese patients with \u03b2 thalassemia major in Taiwan","volume":"11","author":"Yu-Hua Chao","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2024.103878_bib21","first-page":"233","article-title":"A critique of the theoretical hazard of inter vs. intra-racial transfusion","volume":"14","author":"ER","year":"1961","journal-title":"Transfusion"},{"issue":"19","key":"10.1016\/j.transci.2024.103878_bib22","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2009-06-227793","article-title":"Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies","volume":"114","author":"Tormey","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2024.103878_bib23","first-page":"4","article-title":"Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review","volume":"17","author":"Franchini","year":"2019","journal-title":"Blood Transfus"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T05:47:02Z","timestamp":1712209622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1473050224000107"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103878","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of unexpected antibodies in patients with blood disorders: Evidence in Vietnam","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103878"}}